Jundishapur Journal of Microbiology

Published by: Kowsar

In Vitro Activity of Colistin and Trimethoprim/Sulfamethoxazole Against Consortia of Multidrug Resistant Non-Fermenting Gram-Negative Bacilli Isolated from Lower Respiratory Tract

Emese Juhasz 1 , * , Andrea Kovacs 1 , Julia Pongracz 1 , Miklos Ivan 1 and Katalin Kristof 1
Authors Information
1 Diagnostic Laboratory of Clinical Microbiology, Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary
Article information
  • Jundishapur Journal of Microbiology: July 2017, 10 (7); e14034
  • Published Online: June 11, 2017
  • Article Type: Research Article
  • Received: October 15, 2016
  • Revised: March 11, 2017
  • Accepted: March 18, 2017
  • DOI: 10.5812/jjm.14034

To Cite: Juhasz E, Kovacs A, Pongracz J, Ivan M, Kristof K. In Vitro Activity of Colistin and Trimethoprim/Sulfamethoxazole Against Consortia of Multidrug Resistant Non-Fermenting Gram-Negative Bacilli Isolated from Lower Respiratory Tract, Jundishapur J Microbiol. 2017 ; 10(7):e14034. doi: 10.5812/jjm.14034.

Copyright © 2017, Jundishapur Journal of Microbiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
3. Methods
4. Results
5. Discussion
  • 1. Zhang H, Zhang Q. Clinical efficacy and safety of colistin treatment in patients with pulmonary infection caused by Pseudomonas aeruginosa or Acinetobacter baumannii: a meta-analysis. Arch Med Sci. 2015; 11(1): 34-42[DOI][PubMed]
  • 2. Demirdal T, Sari US, Nemli SA. Is inhaled colistin beneficial in ventilator associated pneumonia or nosocomial pneumonia caused by Acinetobacter baumannii? Ann Clin Microbiol Antimicrob. 2016; 15: 11[DOI][PubMed]
  • 3. van Belkum A, Halimi D, Bonetti EJ, Renzi G, Cherkaoui A, Sauvonnet V, et al. Meropenem/colistin synergy testing for multidrug-resistant Acinetobacter baumannii strains by a two-dimensional gradient technique applicable in routine microbiology. J Antimicrob Chemother. 2015; 70(1): 167-72[DOI][PubMed]
  • 4. Silbert S, Pfaller MA, Hollis RJ, Barth AL, Sader HS. Evaluation of three molecular typing techniques for nonfermentative Gram-negative bacilli. Infect Control Hosp Epidemiol. 2004; 25(10): 847-51[DOI][PubMed]
  • 5. Performance Standards for Antimicrobial Susceptibility testing. CLSI approved Standard. 2014;
  • 6. Breakpoints. 2014;
  • 7. Garcia L. Clinical Microbiology Procedures Handbook. 2010;
  • 8. Vidaillac C, Benichou L, Duval RE. In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates. Antimicrob Agents Chemother. 2012; 56(9): 4856-61[DOI][PubMed]
  • 9. Kadar B, Kocsis B, Toth A, Damjanova I, Szasz M, Kristof K, et al. Synergistic antibiotic combinations for colistin-resistant Klebsiella pneumoniae. Acta Microbiol Immunol Hung. 2013; 60(2): 201-9[DOI][PubMed]
  • 10. Marchaim D, Perez F, Lee J, Bheemreddy S, Hujer AM, Rudin S, et al. "Swimming in resistance": Co-colonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosa. Am J Infect Control. 2012; 40(9): 830-5[DOI][PubMed]
  • 11. Juhasz E, Krizsan G, Lengyel G, Grosz G, Pongracz J, Kristof K. Infection and colonization by Stenotrophomonas maltophilia: antimicrobial susceptibility and clinical background of strains isolated at a tertiary care centre in Hungary. Ann Clin Microbiol Antimicrob. 2014; 13: 333[DOI][PubMed]
  • 12. Abbott IJ, Slavin MA, Turnidge JD, Thursky KA, Worth LJ. Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment. Expert Rev Anti Infect Ther. 2011; 9(4): 471-88[DOI][PubMed]
  • 13. Giamarellos-Bourboulis EJ, Karnesis L, Giamarellou H. Synergy of colistin with rifampin and trimethoprim/sulfamethoxazole on multidrug-resistant Stenotrophomonas maltophilia. Diagn Microbiol Infect Dis. 2002; 44(3): 259-63[PubMed]
  • 14. Falagas ME, Vardakas KZ, Roussos NS. Trimethoprim/sulfamethoxazole for Acinetobacter spp.: A review of current microbiological and clinical evidence. Int J Antimicrob Agents. 2015; 46(3): 231-41[DOI][PubMed]
  • 15. Nepka M, Perivolioti E, Kraniotaki E, Politi L, Tsakris A, Pournaras S. In Vitro Bactericidal Activity of Trimethoprim-Sulfamethoxazole Alone and in Combination with Colistin against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates. Antimicrob Agents Chemother. 2016; 60(11): 6903-6[DOI][PubMed]
  • 16. Bae S, Kim MC, Park SJ, Kim HS, Sung H, Kim MN, et al. In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2016; 60(11): 6774-9[DOI][PubMed]
  • 17. Doern CD. When does 2 plus 2 equal 5? A review of antimicrobial synergy testing. J Clin Microbiol. 2014; 52(12): 4124-8[DOI][PubMed]
  • 18. Pompilio A, Crocetta V, De Nicola S, Verginelli F, Fiscarelli E, Di Bonaventura G. Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm. Front Microbiol. 2015; 6: 951[DOI][PubMed]
  • 19. Varposhti M, Entezari F, Feizabadi MM. Synergistic interactions in mixed-species biofilms of pathogenic bacteria from the respiratory tract. Rev Soc Bras Med Trop. 2014; 47(5): 649-52[PubMed]
  • 20. El-Halfawy OM, Valvano MA. Chemical communication of antibiotic resistance by a highly resistant subpopulation of bacterial cells. PLoS One. 2013; 8(7)[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments